Risk Factors of Rebleeding After Peptic Ulcer Bleeding: a Nationwide Cohort Study
NCT ID: NCT02152904
Last Updated: 2016-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
892 participants
OBSERVATIONAL
2014-04-30
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Factors for Rebleeding in Patients With Obscure Gastrointestinal Bleeding
NCT01821326
Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents
NCT02840929
Natural History of Non-steroidal Anti-inflammatory Drug and Non-Helicobacter Pylori in Bleeding Peptic Ulcers
NCT00153712
Survey of Non-Variceal Upper Gastro Intestinal Bleeding in Vietnamese Patients
NCT01292915
The Selection Criteria for the Second-look Endoscopy Among Patients With Bleeding Peptic Ulcers
NCT02197039
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Peptic ulcer bleeding patients
Endoscopy
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who consent to be enrolled in the study
Exclusion Criteria
20 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Joon Sung Kim
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joon Sung Kim
Clinical assistant proffessor, Department of Internal medicine, Incheon St. Mary's Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Byung-Wook Kim, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Incheon St. Mary's Hospital, The Catholic University of Korea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Incheon St. Mary's Hospital
Incheon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KPUB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.